Leukemia and Lymphoma Society Lessens Financial Burden for Patients

1. Leukemia and Lymphoma Society
Lessens Financial Burden for
Patients
By: Ellen Scharaga

2. Leukemia and Lymphoma Society Lessens Financial
Burden for Patients
As an operational consultant for the pharmaceutical company Alegria, Ellen Scharaga supports the
company’s efforts to develop innovative treatments for chronic illnesses. Ellen Scharaga is also a
member of several healthcare-focused professional organizations and charities, including the
Leukemia & Lymphoma Society (LLS).

3. Leukemia and Lymphoma Society Lessens Financial
Burden for Patients
First established in the 1950s to reduce leukemia’s mortality rate, LLS is a leading nonprofit
organization dedicated to supporting cancer research and treatment while supporting patients and
their families. LLS also advocates for policies and practices that improve patient outcomes.

4. Leukemia and Lymphoma Society Lessens Financial
Burden for Patients
In 2019, the nonprofit released a statement requesting policy changes that will increase the
affordability of cancer treatments. Beyond this advocacy, LLS offers several direct financial
assistance programs to patients.

5. Leukemia and Lymphoma Society Lessens Financial
Burden for Patients
The Patient Aid Program offers a small stipend to those undergoing treatment, while the Co-pay
Assistance Program helps eligible families offset the cost of out-of-pocket prescription and
premium costs. Families in severe need can qualify for the Urgent Need Program, which helps
cover a portion of daily living expenses for a year.